Literature DB >> 9269949

Ionic mechanism responsible for prolongation of cardiac action-potential duration by berberine.

Y X Wang1, Y M Zheng.   

Abstract

This study was designed to investigate the effects of berberine on membrane currents forming the repolarization phase of action potentials in isolated guinea pig ventricular myocytes by using the patch-clamp technique. Application of berberine (3-30 microM) to the current-clamped myocytes produced a significant prolongation of action-potential duration (APD), which was concentration dependent. However, this agent (3-30 microM) did not affect the resting potential and action-potential amplitude. The prolongation of APD caused by berberine was not attenuated by tetrodotoxin (TTX, 10 microM), and TTX (10 microM) failed to shorten APD in cells pretreated with 30 microM berberine. Under the voltage-clamp conditions, berberine (3-30 microM) inhibited the delayed rectifier K+ currents (I(K)). Under conditions in which the rapidly activating components (I(Kr)) and slowly activating component (I(Ks)) were dissected out, berberine was shown to block I(Ks) without affecting I(Kr). Application of berberine (3-30 microM) increased the Na+-Ca2+ exchange currents, which were completely abolished by 5 mM NiCl. The L-type Ca2+ currents (I(Ca)) also were increased by 3-30 microM berberine, but the threshold potential, the potential at which I(Ca) was maximal, and the apparent reversal potential remained unchanged. Berberine at either 3 or 30 microM did not affect the inward rectifier K+ currents. This study suggests that the prolongation of cardiac repolarization by berberine is mainly caused by the inhibition of I(Ks) and increase of I(Ca).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269949     DOI: 10.1097/00005344-199708000-00010

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence.

Authors:  Lujiang Yuan; Dawei Tu; Xiaoli Ye; Jianping Wu
Journal:  Plant Foods Hum Nutr       Date:  2006-09       Impact factor: 3.921

2.  Preparative separation of quaternary ammonium alkaloids from Corydalis yanhusuo W. T. Wang by pH-zone-refining counter-current chromatography.

Authors:  Qing Yu; Shengqiang Tong; Jizhong Yan; Chaoqun Hong; Wenfeng Zhai; Yaqin Li
Journal:  J Sep Sci       Date:  2011-01-07       Impact factor: 3.645

3.  Inhibitory effects of berberine on ion channels of rat hepatocytes.

Authors:  Fang Wang; Hong-Yi Zhou; Gang Zhao; Li-Ying Fu; Lan Cheng; Jian-Guo Chen; Wei-Xing Yao
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

4.  Alterations of Blood Pressure and ECG following Two-Week Consumption of Berberis integerrima Fruit Extract.

Authors:  Siyavash Joukar; Naser Mahdavi
Journal:  Int Sch Res Notices       Date:  2014-10-29

Review 5.  Study progress of berberine for treating cardiovascular disease.

Authors:  Le-Min Xia; Mei-Hong Luo
Journal:  Chronic Dis Transl Med       Date:  2016-01-12

Review 6.  Berberis vulgaris for cardiovascular disorders: a scoping literature review.

Authors:  Abdelrahman Ibrahim Abushouk; Amr Muhammad Abdo Salem; Mohamed M Abdel-Daim
Journal:  Iran J Basic Med Sci       Date:  2017-05       Impact factor: 2.699

7.  A randomized, multicenter and noninferiority study of amoxicillin plus berberine vs tetracycline plus furazolidone in quadruple therapy for Helicobacter pylori rescue treatment.

Authors:  Jian Zhang; Chuan Han; Wen Quan Lu; Na Wang; Si Ran Wu; Yong Xi Wang; Jin Ping Ma; Jie Hong Wang; Cheng Hao; Dong Hong Yuan; Na Liu; Yong Quan Shi
Journal:  J Dig Dis       Date:  2020-06-09       Impact factor: 2.325

Review 8.  Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence.

Authors:  Danesh Soltani; Bayan Azizi; Roja Rahimi; Azita H Talasaz; Hossein Rezaeizadeh; Ali Vasheghani-Farahani
Journal:  Front Cardiovasc Med       Date:  2022-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.